开启辅助访问 购买速递币 快速注册 找回密码 切换风格

科研速递论坛

530

主题

13

好友

13

积分

炉火纯青

Rank: 4

科研币
26
速递币
22352
娱乐币
2917
文献值
903
资源值
10
贡献值
0
跳转到指定楼层
楼主
发表于 2016-1-10 14:05:19 |只看该作者 |倒序浏览
速递书局
封面:
题名: Biosimilars and Interchangeable Biologics: Strategic Elements
作者: Sarfaraz K. Niazi
出版社: CRC
出版日期: 2015-12-01
ISBN: 9781498743488
附属页: 齐全
书签:
格式: 清晰PDF
内容简介: Features

Examines the regulatory, marketing, and intellectual property challenges to carve out a stable marketing strategy
Features an understanding of global regulations in developing a comprehensive plan
Incorporates the author’s firsthand experience in developing biosimilar drugs for both the US and European markets

Summary

What’s the Deal with Biosimilars?

Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development.

Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets issues surrounding biosimilars that are linked to legal matters. This includes principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. It addresses the complexity of biosimilar products, and it discusses the utilization of biosimilars and related biological drugs in expanding world markets.

Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. It considers strategic planning elements that include an overall understanding of the history and the current status of the art and science of biosimilars, and it provides detailed descriptions of the legal, regulatory, and commercial characteristics. The book also presents a global strategy on how to build, take to market, and manage the next generation of biosimilars throughout their life cycle.
求助帖链接: http://www.expaper.cn/forum.php?mod=viewthread&tid=106107
本帖最后由 eli.123 于 2016-1-10 14:24 编辑

75 MB, PDF
游客,如果您要查看本帖隐藏内容请回复

本帖子中包含更多资源

您需要 登录 才可以下载或查看,没有帐号?快速注册

已有 1 人评分速递币 文献值 收起 理由
fenglin520 + 50 + 4

总评分: 速递币 + 50  文献值 + 4   查看全部评分

728

主题

3

好友

8

积分

渐入佳境

Rank: 3Rank: 3

科研币
40
速递币
1670
娱乐币
12624
文献值
0
资源值
0
贡献值
0
沙发
发表于 2016-1-10 18:20:35 |只看该作者
多谢高手,辛苦了

0

主题

0

好友

0

积分

初学乍练

Rank: 1

科研币
0
速递币
0
娱乐币
31
文献值
0
资源值
0
贡献值
0
板凳
发表于 2016-2-3 15:43:55 |只看该作者
感谢分享

0

主题

0

好友

0

积分

初学乍练

Rank: 1

科研币
0
速递币
2
娱乐币
2
文献值
0
资源值
0
贡献值
0
地板
发表于 2016-4-2 21:44:50 |只看该作者
多谢高手,感谢分享

1

主题

0

好友

1

积分

登堂入室

Rank: 2

科研币
5
速递币
43
娱乐币
904
文献值
0
资源值
0
贡献值
0
5#
发表于 2016-4-3 09:07:19 |只看该作者
生物类似药,现在是热门啊!谢谢楼主!
您需要登录后才可以回帖 登录 | 快速注册

发布主题 !fastreply! 返回列表 官方QQ群

QQ|Translate Forum into English|QQ群:821993|Archiver|手机版|申请友链| 科研速递论坛

GMT+8, 2024-11-11 23:46 , Processed in 0.099710 second(s), 35 queries .

© 2012-2099 www.expaper.cn

!fastreply! 回顶部 !return_list!